Acadia Pharma (ACAD) NUPLAZID NDA Accepted for Review; 05/01/16 PDUFA Date Set
Go back to Acadia Pharma (ACAD) NUPLAZID NDA Accepted for Review; 05/01/16 PDUFA Date SetAcadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 18.49 +0.29 (1.59%) | |||||
---|---|---|---|---|---|---|
Previous Close | $18.20 | 52 Week High | $42.49 | |||
Open | $18.20 | 52 Week Low | $16.64 | |||
Day High | $18.50 | P/E | N/A | |||
Day Low | $18.36 | EPS | $-0.42 | |||
Volume | 1,531,606 |